Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Large-scale testing (Phase 3)Study completedNCT02407236
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, UlcerativeInflammatory Bowel Diseases
Janssen Research & Development, LLC 961
Large-scale testing (Phase 3)Study completedNCT04706793
What this trial is testing

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Who this might be right for
Ulcerative Colitis
Pfizer 42
Testing effectiveness (Phase 2)Looking for participantsNCT06598943
What this trial is testing

Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 143
Early research (Phase 1)Ended earlyNCT06681389
What this trial is testing

NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

Who this might be right for
Healthy Adult VolunteersActive Ulcerative ColitisActive Ulcerative Colitis (UC)
NIBEC Co., Ltd. 35
Large-scale testing (Phase 3)Ended earlyNCT00488774
What this trial is testing

An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 291
Testing effectiveness (Phase 2)Looking for participantsNCT07507513
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Who this might be right for
Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT05731128
What this trial is testing

Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

Who this might be right for
Colitis Ulcerative
Sanofi 68
Large-scale testing (Phase 3)Study completedNCT01532648
What this trial is testing

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 510
Large-scale testing (Phase 3)Study completedNCT00713310
What this trial is testing

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Warner Chilcott 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535489
What this trial is testing

Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

Who this might be right for
Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd 144
Testing effectiveness (Phase 2)Study completedNCT05377580
What this trial is testing

Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Innovent Biologics (Suzhou) Co. Ltd. 150
Early research (Phase 1)Study completedNCT02818686
What this trial is testing

TD-1473 for Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Theravance Biopharma 40
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Large-scale testing (Phase 3)Study completedNCT05507216
What this trial is testing

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Who this might be right for
Ulcerative Colitis
Abivax S.A. 636
Not applicableUnknownNCT06469424
What this trial is testing

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

Who this might be right for
Ulcerative Colitis
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 104
Testing effectiveness (Phase 2)Study completedNCT05831670
What this trial is testing

An Early Phase 2 Clinical Study of KSP-0243

Who this might be right for
Colitis, Ulcerative
Kissei Pharmaceutical Co., Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT02447302
What this trial is testing

Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 156
Large-scale testing (Phase 3)Study completedNCT02665845
What this trial is testing

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

Who this might be right for
Ulcerative Colitis
Centre Hospitalier Universitaire de Saint Etienne 160
Testing effectiveness (Phase 2)Ended earlyNCT04556383
What this trial is testing

A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
GB004, Inc. 236
Next Page